Variant thyroxine-binding globulin in serum of Australian Aborigines: a comparison with familial TBG deficiency in Caucasians and American Blacks

Abstract
About 40% of clinically euthyroid Australian Aborigines have low concentrations of total thyroxine (TT4) and triiodothyronine (TT3) in serum. While the finding of normal concentrations of serum thyrotropin (TSH) in such individuals is compatible with their eumetabolic state, the reason for the finding of a low free T4 index (FT4I) has been unclear. A genetic variant of T4-binding globulin (TBG) with reduced affinity for T4 has been suggested but decrease in the absolute concentration of TBG has also been reported. In this study, we measured various parameters of thyroid function in 20 serum samples from euthyroid Australian Aborigines selected for their low TT4 levels. Results were compared to those obtained in serum samples from Caucasians and American Blacks with inherited partial TBG deficiency, 15 of which were matched to the Aborigines by their TBG and 20 by their TT4 concentrations. Results were also compared with those from another group of 20 samples from Caucasians and American Blacks with normal TBG concentration, matched to the Aborigines by their serum TT4 concentration. TBG in serum from these Australian Aborigines was immunologically identical to that in Caucasians and American Blacks in terms of parallelism of serially diluted samples in the TBG radioimmunoassay (RIA). Comparison of measurements of TBG concentration by RIA and by T4-binding capacity (CAP) gave identical results indicating that, in Aborigines as in non-Aborigines, TBG molecules have a single T4-binding site. Serum TBG concentration in this group of Aborigines with lowTT4was 1.1 ± 0.3 mg/dl (mean ± SD) and significantly lower (p< 0.001) than that in non-Aborigines of 1.6 ± 0.2 mg/dl. When the Aboriginal samples were matched to euthyroid Caucasians and American Blacks by their TBG concentration, their mean TT4 concentration was significantly lower (4.1 ± 0.8µg/dl vs. 5.6 ± 1.1 µg/dl, p < 0.001), as was their mean TT3 concentration (88 ± 17 ng/dl vs. 139 ± 27 ng/dl, p < 0.001). In contrast when matched by their TT4 concentration, the mean serum TBG level was significantly higher (1.1 ± 0.3 mg/dl vs. 0.7 ± 0.3 mg/dl, p < 0.001). TSH concentration was normal and not significantly different in the Aborigines and the two non-Aboriginal groups with familial partial TBG deficiency. All serum samples from non-Aborigines with normal TBG which were matched to the Aborigines by their TT4 concentration had high serum TSH values and thus belonged to patients with primary hypothyroidism. The mean FT4I value was significantly (p < 0.001) lower in the Aborigines (4.9 ± 1.0) as compared to the two euthyroid non-Aboriginal groups matched by their TBG or TT4 (7.4 ± 0.8 and 7.5 ± 1.3, respectively). In contrast, the free T4 (FT4) values measured by equilibrium dialysis in 5 Aboriginal samples spanned over the same normal range as that of 8 euthyroid non-Aborigines. There was an excellent correlation between the FT4I and FT4 in both Aborigines and non-Aborigines (r = 0.957 and 0.918 respectively). However, the slopes of the two regression lines were significantly different (p < 0.001). These results indicate that the degree of reduction of TT4 and TT3 concentration in euthyroid Australian Aborigines cannot be explained solely on the basis of diminished serum TBG level. They support the hypothesis that such individuals have a variant TBG with reduced affinity for T4 and T3.